Abstract:Background : Amyotrophic lateral sclerosis (ALS) is an old onset devastating neurodegenerative disorder. Young-onset ALS cases especially sporadic ones who are between 25 and 45 years are rarely affected by the disease. Despite the identification of numerous candidate genes associated with ALS, the etiology of the disease remains elusive due to extreme genetic and phenotypic variability. The advent of affordable whole exome sequencing (WES) has opened new avenues for unraveling the disease's pathophysiology better. Methods and results : We aimed to determine the genetic basis of an Indian-origin, young onset sporadic ALS patient with very rapid deterioration of the disease course without any cognitive decline who was screened for mutations in major ALS candidate genes by WES. Variants detected were reconfirmed by Sanger sequencing. The clinicopathological features were investigated and two heterozygous missense variants were identified: R452W, not previously associated with ALS, present in one of the four conserved C terminal domains in ANXA11 and R208W in SIGMAR1 , respectively. Both of these variants were predicted to be damaging by pathogenicity prediction tools and various in silico methods. Conclusion : Our study revealed two potentially pathogenic variants in two ALS candidate genes. The genetic makeup of ALS patients from India has been the subject of a few prior studies, but none of them examined ANXA11 and SIGMAR1 genes so far. These results establish the framework for additional research into the pathogenic processes behind these variations that result in sporadic ALS disease and further our understanding of the genetic makeup of Indian ALS patients.

Recent advances in the genetics of familial and sporadic ALS

The genetics and neuropathology of amyotrophic lateral sclerosis

Recent Updates on the Genetics of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

The genetics of amyotrophic lateral sclerosis

Recent progress of the genetics of amyotrophic lateral sclerosis and challenges of gene therapy

Amyotrophic Lateral Sclerosis Genetic Studies

Novel Pathogenic Variants Leading to Sporadic Amyotrophic Lateral Sclerosis in Greek Patients

Controversies and priorities in amyotrophic lateral sclerosis

ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now?

Integrative genetic analysis illuminates ALS heritability and identifies risk genes

Presence of Rare Variants is Associated with Poorer Survival in Chinese Patients with Amyotrophic Lateral Sclerosis.

Genetic and in silico analysis of Indian sporadic young onset patient with amyotrophic lateral sclerosis

Genotype-phenotype relationship in hereditary amyotrophic lateral sclerosis

Genetic Spectrum and Variability in Chinese Patients with Amyotrophic Lateral Sclerosis.

Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis

Amyotrophic lateral sclerosis: translating genetic discoveries into therapies

Concomitant presence of a novel ARPP21 variant and CNVs in Chinese familial amyotrophic lateral sclerosis-frontotemporal dementia patients

Amyotrophic Lateral Sclerosis (ALS): An Overview of Genetic and Metabolic Signaling Mechanisms

Variability in SOD1-associated amyotrophic lateral sclerosis: geographic patterns, clinical heterogeneity, molecular alterations, and therapeutic implications

Frameshift and Novel Mutations in Fus in Familial Amyotrophic Lateral Sclerosis and Als/Dementia

Translating the ALS Genetic Revolution into Therapies: A Review